Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (121-130 of 377) with videos related to

Pageof 38
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2018
The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for <sup>177</sup>Lu-Labeled PSMA PeptidesNusrat J Begum, Anne Thieme, Nina Eberhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2020
A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patientsJan C Peeken, Mohamed A Shouman, Markus Kroenke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 15, 2015
Discrimination Between Brown and White Adipose Tissue Using a 2-Point Dixon Water-Fat Separation Method in Simultaneous PET/MRIDaniela Franz, Dimitrios C Karampinos, Ernst J Rummeny, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancerThomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
Radiation Oncology (London, England)|May 28, 2016
Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective studySabrina Dewes, Kilian Schiller, Katharina Sauter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
First Experiences with <sup>177</sup>Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single PatientsVikas Prasad, Friedemann Zengerling, Jochen P Steinacker, et al.
European Urology|December 10, 2021
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission TomographyValentin H Meissner, Isabel Rauscher, Kristina Schwamborn, et al.
Radiation Oncology (London, England)|May 2, 2021
A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancerMarco M E Vogel, Sabrina Dewes, Eva K Sage, et al.
European Journal of Hybrid Imaging|April 16, 2023
Is there more than meets the eye in PSMA imaging in prostate cancer with PET/MRI? Looking closer at uptake time, correlation with PSA and Gleason scoreBorjana Bogdanovic, Esteban L Solari, Alberto Villagran Asiares, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2026
Value of a repeat <sup>18</sup>F-flotufolastat PET scan following a negative scan in patients with suspected biochemical recurrence of prostate cancer after radical prostatectomySonja Kirchhoff, Andreas Lederer, Theo Lorenzini, et al.
Pageof 38

Showing results (121-130 of 377) with videos related to

Sort By:
Pageof 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2018
The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for <sup>177</sup>Lu-Labeled PSMA PeptidesNusrat J Begum, Anne Thieme, Nina Eberhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2020
A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patientsJan C Peeken, Mohamed A Shouman, Markus Kroenke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 15, 2015
Discrimination Between Brown and White Adipose Tissue Using a 2-Point Dixon Water-Fat Separation Method in Simultaneous PET/MRIDaniela Franz, Dimitrios C Karampinos, Ernst J Rummeny, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancerThomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
Radiation Oncology (London, England)|May 28, 2016
Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective studySabrina Dewes, Kilian Schiller, Katharina Sauter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
First Experiences with <sup>177</sup>Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single PatientsVikas Prasad, Friedemann Zengerling, Jochen P Steinacker, et al.
European Urology|December 10, 2021
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission TomographyValentin H Meissner, Isabel Rauscher, Kristina Schwamborn, et al.
Radiation Oncology (London, England)|May 2, 2021
A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancerMarco M E Vogel, Sabrina Dewes, Eva K Sage, et al.
European Journal of Hybrid Imaging|April 16, 2023
Is there more than meets the eye in PSMA imaging in prostate cancer with PET/MRI? Looking closer at uptake time, correlation with PSA and Gleason scoreBorjana Bogdanovic, Esteban L Solari, Alberto Villagran Asiares, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2026
Value of a repeat <sup>18</sup>F-flotufolastat PET scan following a negative scan in patients with suspected biochemical recurrence of prostate cancer after radical prostatectomySonja Kirchhoff, Andreas Lederer, Theo Lorenzini, et al.
Pageof 38